% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • eureka201213 eureka201213 Mar 25, 2012 1:02 PM Flag

    Pfizer's intermediate-term angle of ascent still too sharp

    The line connecting the intraday low of $18.15 on Nov. 25 with the intraday low of $20.75 on Feb. 27 is ascending at the rate of 83.9 cents a month. That's too sharp to be sustained and it would be healthy for the stock to give up 75 cents to a buck to get down to a line of ascent at 65 or 70 cents a month that could be sustained.

32.18-0.36(-1.11%)Oct 21 4:00 PMEDT